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Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate On Cardiac Arrhythmias in Rats
Keywords Beta-hydroxy-beta-methylbutyrate; Myocardial Ischemia; Arrhythmias Fibrillation Aims One of the major factors in sudden cardiac arrest is the initiation and continuation of deadly arrhythmias during ischemia. It is known that beta-hydroxy-beta-methylbutyrate (HMB) has useful effects such as anti-inflammatory and anti-apoptosis effects in the skeletal muscles. The aim of this study was to investigate the preventive effects of HMB on the ventricular arrhythmias due to the ischemia.
Materials & Methods
In this case-control, 15 patients with knee osteoarthritis referred to the physiotherapy clinic of the rehabilitation center and Al-Zahra hospital were studied in the muscle-skeletal research center of Isfahan University of Medical Sciences in 2015. The subjects were selected via stratified sampling method. As control group, 15 healthy persons were also studied in Isfahan. Total path length and the domain and frequency of pressure center in different directions were measured to assess the stability. Data was analyzed by SPSS 19 software using descriptive statistics and paired T test. Findings There was a significant reduction in the mean PVC number in HMB320 and HMB700 groups than control group (p=0.001). In addition, there was such a significant difference between the groups received the doses (p=0.008). There was a reduction in the mean appearance duration of VT in HMB320 and HMB700 groups than control group (p=0.001).
There was a significant reduction in the mean appearance duration of VF in HMB700 group compared to control group, only (p=0.003). Conclusion Through arrhythmias reduction, 2-week preventive consumption of HMB might considerably reduce the severe side effects of ischemia. . SPSS 16 .
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